Rocket Pharmaceuticals (RCKT) Shares Outstanding (2014 - 2026)

Rocket Pharmaceuticals (RCKT) has 12 years of Shares Outstanding (Entity) data on file, last reported at $109.1 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Entity) rose 2.22% year-over-year to $109.1 million; the trailing twelve-month figure through Mar 2026 stood at $109.1 million (up 2.22% YoY), and the FY2025 full-year result was $108.3 million, up 1.75% from the prior year.
• Shares Outstanding (Entity) rose to $109.1 million in Q1 2026, from $108.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $109.1 million in Q1 2026 to a low of $64.5 million in Q1 2022.
• A 5-year average of $90.5 million and a median of $90.6 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) soared 32.88% in 2023 and advanced 1.08% in 2024, its largest moves.
• Tracing RCKT's Shares Outstanding (Entity) over 5 years: stood at $79.1 million in 2022, then climbed by 14.1% to $90.3 million in 2023, then gained by 17.91% to $106.5 million in 2024, then grew by 1.75% to $108.3 million in 2025, then grew by 0.74% to $109.1 million in 2026.
• Business Quant data shows RCKT's Shares Outstanding (Entity) at $109.1 million in Q1 2026, $108.3 million in Q4 2025, and $108.2 million in Q3 2025.